Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Jérémie Prévost and Andrés Finzi.
Jérémie Prévost
Connection Strength
8.298
Andrés Finzi
  1. Impact of temperature on the affinity of SARS-CoV-2 Spike glycoprotein for host ACE2. J Biol Chem. 2021 10; 297(4):101151.
    View in: PubMed
    Score: 0.965
  2. The great escape? SARS-CoV-2 variants evading neutralizing responses. Cell Host Microbe. 2021 03 10; 29(3):322-324.
    View in: PubMed
    Score: 0.934
  3. Cross-Sectional Evaluation of Humoral Responses against SARS-CoV-2 Spike. Cell Rep Med. 2020 10 20; 1(7):100126.
    View in: PubMed
    Score: 0.906
  4. Incomplete Downregulation of CD4 Expression Affects HIV-1 Env Conformation and Antibody-Dependent Cellular Cytotoxicity Responses. J Virol. 2018 07 01; 92(13).
    View in: PubMed
    Score: 0.772
  5. Envelope glycoproteins sampling states 2/3 are susceptible to ADCC by sera from HIV-1-infected individuals. Virology. 2018 02; 515:38-45.
    View in: PubMed
    Score: 0.746
  6. Influence of the Envelope gp120 Phe 43 Cavity on HIV-1 Sensitivity to Antibody-Dependent Cell-Mediated Cytotoxicity Responses. J Virol. 2017 04 01; 91(7).
    View in: PubMed
    Score: 0.708
  7. A single dose of the SARS-CoV-2 vaccine BNT162b2 elicits Fc-mediated antibody effector functions and T cell responses. Cell Host Microbe. 2021 07 14; 29(7):1137-1150.e6.
    View in: PubMed
    Score: 0.237
  8. Longitudinal analysis of humoral immunity against SARS-CoV-2 Spike in convalescent individuals up to 8 months post-symptom onset. Cell Rep Med. 2021 06 15; 2(6):100290.
    View in: PubMed
    Score: 0.236
  9. High-throughput detection of antibodies targeting the SARS-CoV-2 Spike in longitudinal convalescent plasma samples. Transfusion. 2021 05; 61(5):1377-1382.
    View in: PubMed
    Score: 0.233
  10. Major role of IgM in the neutralizing activity of convalescent plasma against SARS-CoV-2. Cell Rep. 2021 03 02; 34(9):108790.
    View in: PubMed
    Score: 0.232
  11. Decline of Humoral Responses against SARS-CoV-2 Spike in Convalescent Individuals. mBio. 2020 10 16; 11(5).
    View in: PubMed
    Score: 0.227
  12. Interaction of Human ACE2 to Membrane-Bound SARS-CoV-1 and SARS-CoV-2 S Glycoproteins. Viruses. 2020 09 29; 12(10).
    View in: PubMed
    Score: 0.226
  13. Antibody-Induced Internalization of HIV-1 Env Proteins Limits Surface Expression of the Closed Conformation of Env. J Virol. 2019 06 01; 93(11).
    View in: PubMed
    Score: 0.206
  14. SOSIP Changes Affect Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Conformation and CD4 Engagement. J Virol. 2018 10 01; 92(19).
    View in: PubMed
    Score: 0.196
  15. Impact of HIV-1 Envelope Conformation on ADCC Responses. Trends Microbiol. 2018 04; 26(4):253-265.
    View in: PubMed
    Score: 0.186
  16. Impaired Downregulation of NKG2D Ligands by Nef Proteins from Elite Controllers Sensitizes HIV-1-Infected Cells to Antibody-Dependent Cellular Cytotoxicity. J Virol. 2017 08 15; 91(16).
    View in: PubMed
    Score: 0.182
  17. BST-2 Expression Modulates Small CD4-Mimetic Sensitization of HIV-1-Infected Cells to Antibody-Dependent Cellular Cytotoxicity. J Virol. 2017 06 01; 91(11).
    View in: PubMed
    Score: 0.179
  18. HIV-1 gp120 envelope glycoprotein determinants for cytokine burst in human monocytes. PLoS One. 2017; 12(3):e0174550.
    View in: PubMed
    Score: 0.177
  19. Residues in the gp41 Ectodomain Regulate HIV-1 Envelope Glycoprotein Conformational Transitions Induced by gp120-Directed Inhibitors. J Virol. 2017 03 01; 91(5).
    View in: PubMed
    Score: 0.176
  20. Lineage-Specific Differences between the gp120 Inner Domain Layer 3 of Human Immunodeficiency Virus and That of Simian Immunodeficiency Virus. J Virol. 2016 Nov 15; 90(22):10065-10073.
    View in: PubMed
    Score: 0.172
  21. Live imaging of SARS-CoV-2 infection in mice reveals that neutralizing antibodies require Fc function for optimal efficacy. Immunity. 2021 09 14; 54(9):2143-2158.e15.
    View in: PubMed
    Score: 0.060
  22. SARS-CoV-2 seroprevalence among blood donors in Québec, and analysis of symptoms associated with seropositivity: a nested case-control study. Can J Public Health. 2021 08; 112(4):576-586.
    View in: PubMed
    Score: 0.059
  23. Evaluation of a Commercial Culture-Free Neutralization Antibody Detection Kit for Severe Acute Respiratory Syndrome-Related Coronavirus-2 and Comparison With an Antireceptor-Binding Domain Enzyme-Linked Immunosorbent Assay. Open Forum Infect Dis. 2021 Jun; 8(6):ofab220.
    View in: PubMed
    Score: 0.059
  24. Identification of SARS-CoV-2-specific immune alterations in acutely ill patients. J Clin Invest. 2021 04 15; 131(8).
    View in: PubMed
    Score: 0.059
  25. Waning of SARS-CoV-2 RBD antibodies in longitudinal convalescent plasma samples within 4 months after symptom onset. Blood. 2020 11 26; 136(22):2588-2591.
    View in: PubMed
    Score: 0.057
  26. Real-Time Conformational Dynamics of SARS-CoV-2 Spikes on Virus Particles. Cell Host Microbe. 2020 12 09; 28(6):880-891.e8.
    View in: PubMed
    Score: 0.057
  27. An Asymmetric Opening of HIV-1 Envelope Mediates Antibody-Dependent Cellular Cytotoxicity. Cell Host Microbe. 2019 Apr 10; 25(4):578-587.e5.
    View in: PubMed
    Score: 0.051
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.